Accumulating evidence indicates that AURKA is overexpressed in various cancers, including breast cancer, head and neck cancer, esophagus cancer, hematological malignancies, colorectal cancer, stomach cancer, pancreatic cancer, and ovarian and prostate cancers [50, 51]. This evidence concerns the gene AURKA and breast cancer.